Justice Department, DEA propose reduction of opioid manufacturing quotas

THE DEA has proposed reducing the national manufacturing quotas of several opioid medications to aid in fighting an opoid addiction epidemic in the United States. /BLOOMBERG NEWS FILE PHOTO/KIYOSHI OTA
THE DEA has proposed reducing the national manufacturing quotas of several opioid medications to aid in fighting an opoid addiction epidemic in the United States. /BLOOMBERG NEWS FILE PHOTO/KIYOSHI OTA
WASHINGTON D.C. — The U.S. Department of Justice and U.S. Drug Enforcement Administration have proposed reducing controlled substance manufacturing by between 7 and 15 percent in 2019 by adjusting the DEA’s the aggregate production quote, in the hopes of curbing opioid abuse by limiting the supply.  In setting the aggregate production quote, DEA considers data from many…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -